116 related articles for article (PubMed ID: 12573816)
21. Stromal insulin-like growth factor binding protein 3 (IGFBP3) is elevated in the diseased human prostate and promotes ex vivo fibroblast-to-myofibroblast differentiation.
Sampson N; Zenzmaier C; Heitz M; Hermann M; Plas E; Schäfer G; Klocker H; Berger P
Endocrinology; 2013 Aug; 154(8):2586-99. PubMed ID: 23720424
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor (IGF)-I controls prostate fibromuscular development: IGF-I inhibition prevents both fibromuscular and glandular development in eugonadal mice.
Kleinberg DL; Ruan W; Yee D; Kovacs KT; Vidal S
Endocrinology; 2007 Mar; 148(3):1080-8. PubMed ID: 17138659
[TBL] [Abstract][Full Text] [Related]
23. Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells.
Wadsworth TL; Carroll JM; Mallinson RA; Roberts CT; Roselli CE
Endocrinology; 2004 Jul; 145(7):3205-14. PubMed ID: 15033918
[TBL] [Abstract][Full Text] [Related]
24. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
[TBL] [Abstract][Full Text] [Related]
25. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.
Fibbi B; Penna G; Morelli A; Adorini L; Maggi M
Int J Androl; 2010 Jun; 33(3):475-88. PubMed ID: 19508330
[TBL] [Abstract][Full Text] [Related]
26. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.
Li W; Wu CL; Febbo PG; Olumi AF
Am J Pathol; 2007 Oct; 171(4):1189-98. PubMed ID: 17702894
[TBL] [Abstract][Full Text] [Related]
27. Expression and cellular localization of keratinocyte growth factor and its receptor in human hyperplastic prostate tissue.
De Bellis A; Crescioli C; Grappone C; Milani S; Ghiandi P; Forti G; Serio M
J Clin Endocrinol Metab; 1998 Jun; 83(6):2186-91. PubMed ID: 9626158
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia.
Dong G; Rajah R; Vu T; Hoffman AR; Rosenfeld RG; Roberts CT; Peehl DM; Cohen P
J Clin Endocrinol Metab; 1997 Jul; 82(7):2198-203. PubMed ID: 9215294
[TBL] [Abstract][Full Text] [Related]
29. Stromal cells of the human prostate: initial isolation and characterization.
Kassen A; Sutkowski DM; Ahn H; Sensibar JA; Kozlowski JM; Lee C
Prostate; 1996 Feb; 28(2):89-97. PubMed ID: 8604397
[TBL] [Abstract][Full Text] [Related]
30. TRAF6 regulates proliferation of stromal cells in the transition and peripheral zones of benign prostatic hyperplasia via Akt/mTOR signaling.
Shi YF; Yu DJ; Jiang CY; Wang XJ; Zhu YP; Zhao RZ; Lv Z; Sun XW
Prostate; 2018 Feb; 78(3):193-201. PubMed ID: 29171041
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor II and androgen receptor expression in the prostate.
Gnanapragasam VJ; McCahy PJ; Neal DE; Robson CN
BJU Int; 2000 Oct; 86(6):731-5. PubMed ID: 11069386
[TBL] [Abstract][Full Text] [Related]
32. Anti-proliferative activities of finasteride in benign prostate epithelial cells require stromal fibroblasts and c-Jun gene.
Wang K; Jin S; Fan D; Wang M; Xing N; Niu Y
PLoS One; 2017; 12(2):e0172233. PubMed ID: 28196103
[TBL] [Abstract][Full Text] [Related]
33. Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell.
Kim JH; Kim SS; Han IH; Sim S; Ahn MH; Ryu JS
Prostate; 2016 Nov; 76(15):1431-44. PubMed ID: 27325623
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation.
Kramer G; Steiner GE; Handisurya A; Stix U; Haitel A; Knerer B; Gessl A; Lee C; Marberger M
Prostate; 2002 Jun; 52(1):43-58. PubMed ID: 11992619
[TBL] [Abstract][Full Text] [Related]
35. Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia.
Wang Z; Olumi AF
Differentiation; 2011; 82(4-5):261-71. PubMed ID: 21536370
[TBL] [Abstract][Full Text] [Related]
36. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
Tang DG; Li L; Chopra DP; Porter AT
Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
[TBL] [Abstract][Full Text] [Related]
37. Androgen receptor roles in the development of benign prostate hyperplasia.
Izumi K; Mizokami A; Lin WJ; Lai KP; Chang C
Am J Pathol; 2013 Jun; 182(6):1942-9. PubMed ID: 23570837
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
Giri D; Ittmann M
Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor-I (IGF-I) and its binding protein IGFBP-4 in human prostatic hyperplastic tissue: gene expression and its cellular localization.
Barni T; Vannelli BG; Sadri R; Pupilli C; Ghiandi P; Rizzo M; Selli C; Serio M; Fiorelli G
J Clin Endocrinol Metab; 1994 Mar; 78(3):778-83. PubMed ID: 7510307
[TBL] [Abstract][Full Text] [Related]
40. The GnRH Antagonist Degarelix Directly Inhibits Benign Prostate Hyperplasia Cell Growth.
Sakai M; Elhilali M; Papadopoulos V
Horm Metab Res; 2015 Nov; 47(12):925-31. PubMed ID: 26197852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
